Response to Cunill et al.
Hospital Universitari Vall d'Hebron, Adult ADHD Program, Department of Psychiatry, Spain; Biomedical Network Research Centre on Mental Health, CIBERSAM, Spain; Universitat Autònoma de Barcelona, Department of Psychiatry and Legal Medicine, Spain.
J Antoni
JA
Ramos-Quiroga
Pedro
P
Lopez-Romero
Chris
C
Bushe
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D006801:Humans; D010352:Patient Dropouts; D011437:Propylamines / Q000627:therapeutic use*
D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines